Cleared Traditional

K932406 - NUCLITRYP(TM)(I125)-HUMAN PANCREA CATH TRY RAD KIT

K932406 is an FDA 510(k) clearance for NUCLITRYP(TM)(I125)-HUMAN PANCREA CATH ..., manufactured by Nuclear Diagnostics, Inc.. The device is a Class 1 Chemistry device with product code JNO cleared through the Traditional 510(k) pathway after a 203-day FDA review.

K932406 · Nuclear Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1993
Decision
203d
Days
Class 1
Risk

K932406 is an FDA 510(k) clearance for the NUCLITRYP(TM)(I125)-HUMAN PANCREA CATH TRY RAD KIT. Classified as N-benzoyl-l-arginine Ethyl Ester (u.v.), Trypsin (product code JNO), Class I - General Controls.

Submitted by Nuclear Diagnostics, Inc. (Northbrook, US). The FDA issued a Cleared decision on December 2, 1993 after a review of 203 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1725 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nuclear Diagnostics, Inc. devices

FDA 510(k) Submission Details - K932406

510(k) Number K932406 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 13, 1993
Decision Date December 02, 1993
Days to Decision 203 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
115d slower than avg
Panel avg: 88d · This submission: 203d
Pathway characteristics
Predicate-based equivalence.

JNO Device Classification - Class 1, General Controls

Product Code JNO N-benzoyl-l-arginine Ethyl Ester (u.v.), Trypsin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1725
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.